| 
																	
																		 
																		 Estrogen Replacement Therapy
 
																		 
																		
																	 
																		 
																		
																	 
																			
																					
	"Estrogen Replacement Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
 
	
	
		
			
			
				The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.
    
			 
				
				
					
						| Descriptor ID | D015914 |  
						| MeSH Number(s) | E02.319.452.150 |  
						| Concept/Terms | Estrogen Replacement TherapyEstrogen Replacement TherapyEstrogen Replacement TherapiesReplacement Therapies, EstrogenTherapies, Estrogen ReplacementTherapy, Estrogen ReplacementReplacement Therapy, Estrogen
 Estrogen ReplacementEstrogen ReplacementEstrogen ReplacementsReplacements, EstrogenReplacement, Estrogen
 |  
				Below are MeSH descriptors whose meaning is more general than "Estrogen Replacement Therapy". 
				Below are MeSH descriptors whose meaning is more specific than "Estrogen Replacement Therapy". 
	
	
		
			
			
					
				This graph shows the total number of publications written about "Estrogen Replacement Therapy" by people in this website by year, and whether "Estrogen Replacement Therapy" was a major or minor topic of these publications.  
					  To see the data from this visualization as text, click here. 
		            | Year | Major Topic | Minor Topic | Total | 
|---|
 | 1995 | 1 | 2 | 3 |  | 1996 | 3 | 0 | 3 |  | 1997 | 4 | 1 | 5 |  | 1998 | 5 | 1 | 6 |  | 1999 | 0 | 1 | 1 |  | 2000 | 1 | 0 | 1 |  | 2001 | 4 | 0 | 4 |  | 2002 | 5 | 1 | 6 |  | 2003 | 9 | 1 | 10 |  | 2004 | 3 | 2 | 5 |  | 2005 | 2 | 1 | 3 |  | 2006 | 1 | 4 | 5 |  | 2007 | 1 | 0 | 1 |  | 2008 | 8 | 1 | 9 |  | 2009 | 1 | 3 | 4 |  | 2010 | 2 | 2 | 4 |  | 2011 | 3 | 1 | 4 |  | 2012 | 1 | 2 | 3 |  | 2013 | 1 | 3 | 4 |  | 2014 | 3 | 2 | 5 |  | 2015 | 6 | 2 | 8 |  | 2016 | 2 | 0 | 2 |  | 2017 | 1 | 1 | 2 |  | 2018 | 0 | 1 | 1 |  | 2019 | 3 | 1 | 4 |  | 2020 | 4 | 1 | 5 |  | 2021 | 2 | 1 | 3 |  | 2022 | 0 | 1 | 1 |  | 2023 | 2 | 0 | 2 |  | 2024 | 0 | 3 | 3 |  | 2025 | 1 | 1 | 2 | 
 
                    To return to the timeline, click here. 
				Below are the most recent publications written about "Estrogen Replacement Therapy" by people in Profiles. 		
					
								
								Santoro NF, Lawley SD, Sammel MD, Johnson J. Prolonging youth or prolonging perimenopause? Beware the Monkey's Paw. Menopause. 2025 Oct 01; 32(10):978-982.
								Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Kendell-Thomas J, Kapoor E, Faubion LL, Schwarz CG, Senjem ML, Fields JA, Min PH, Lowe VJ, Jack CR, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy. Menopause. 2025 Jan 01; 32(1):12-22.
								Harrington LB, Powers JD, Bayliss EA, Fortmann SP, Shortreed SM, Walker RL, Floyd JS, Kuntz J, Fuller S, Alberston-Junkans L, Lee MH, Temposky LA, Dublin S. Current use of estrogen-containing oral contraceptives or hormone therapy and risk of COVID-19 infection and hospitalization: a population-based cohort study. Am J Epidemiol. 2024 Oct 07; 193(10):1417-1425.
								Santoro N. Basics of the menopause transition. Menopause. 2024 Oct 01; 31(10):921-922.
								Gai X, Feng Y, Flores TM, Kang H, Yu H, Leslie KK, Zhu Y, Doherty JA, Guo Y, Belinsky SA, Cook LS, Leng S. Early menopause and hormone therapy as determinants for lung health outcomes: a secondary analysis using the PLCO trial. Thorax. 2024 09 18; 79(10):961-969.
								Kantarci K, Tosakulwong N, Lesnick TG, Kara F, Kendall-Thomas J, Kapoor E, Fields JA, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Cardiometabolic outcomes in Kronos Early Estrogen Prevention Study continuation: 14-year follow-up of a hormone therapy trial. Menopause. 2024 Jan 01; 31(1):10-17.
								Petrick JL, Joslin CE, Johnson CE, Camacho TF, Peres LC, Bandera EV, Barnard ME, Beeghly A, Bethea TN, Dempsey LF, Guertin K, Harris HR, Moorman PG, Myers ER, Ochs-Balcom HM, Rosenow W, Setiawan VW, Wu AH, Schildkraut JM, Rosenberg L. Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium. Br J Cancer. 2023 12; 129(12):1956-1967.
								Sponholtz TR, Palmer JR, Rosenberg L, Chen C, Chen Y, Clarke MA, Clendenen T, Du M, Johnson L, Liao LM, Michels KA, O'Connell K, Olson SH, Petruzella S, Rebbeck TR, Setiawan VW, Trabert B, Weiss NS, Wentzensen N, Wilkens L, Wise LA. Risk factors for endometrial cancer in Black women. Cancer Causes Control. 2023 May; 34(5):421-430.
								Santoro N, Liss J. Compounded Bioidentical Hormones: Myths and Realities. Clin Obstet Gynecol. 2021 12 01; 64(4):793-802.
								Squiers GT, McLellan MA, Ilinykh A, Branca J, Rosenthal NA, Pinto AR. Cardiac cellularity is dependent upon biological sex and is regulated by gonadal hormones. Cardiovasc Res. 2021 08 29; 117(10):2252-2262. | 
																	
																		
																			
																					People  People who have written about this concept._ 
    
        Similar Concepts   
        People who have written about this concept.
     _ 
    
        Top Journals   
        Top journals in which articles about this concept have been published.
     |